Genprex (GNPX) vs Sunshine Biopharma (SBFM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Genprex is the larger company by market cap ($2.3 million vs $1.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNPX | SBFM |
|---|---|---|
| Share price | $2.75 | $0.43 |
| Market cap | $2.25M | $1.85M |
| 1-day change | +4.96% | -38.57% |
| Forward P/E | — | 0.00 |
| EPS (TTM) | $-9.35 | $-9.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1,210.00 | $24.30 |
| 52-week low | $2.53 | $0.356 |
| Distance from 52-week high | -99.77% | -98.23% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +12923.26% |
| Average volume | 247.06K | 5.25M |
| Shares outstanding | 819.71K | 4.31M |
| Employees | 13 | 50 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Genprex
GNPX stock →Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.
Healthcare · Biotechnology · 13 employees
About Sunshine Biopharma
SBFM stock →Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
Healthcare · Drug Manufacturers - Specialty & Generic · 50 employees
GNPX vs SBFM FAQ
Which is bigger, Genprex or Sunshine Biopharma?
Genprex (GNPX) is larger, with a market capitalization of $2.25M compared with $1.85M for Sunshine Biopharma (SBFM).
Are Genprex and Sunshine Biopharma in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for Genprex and Drug Manufacturers - Specialty & Generic for Sunshine Biopharma.